Research organism

elife

eLife

2050-084X

eLife Sciences Publications, Ltd

83545

10.7554/eLife.83545

Tools and Resources

Neuroscience

Rapid cell type-specific nascent proteome labeling in Drosophila

Villalobos-Cantor

Stefanny

1Barrett

Ruth M

1Condon

Alec F

https://orcid.org/0000-0003-2655-2121

1†Arreola-Bustos

Alicia

1Rodriguez

Kelsie M

https://orcid.org/0000-0002-0821-6717

2Cohen

Michael S

https://orcid.org/0000-0002-7636-4156

2Martin

Ian

https://orcid.org/0000-0002-5912-1777

martiia@ohsu.edu1231

https://ror.org/009avj582

Jungers Center for Neurosciences, Department of Neurology, Oregon Health and Science University

Portland

United States2

https://ror.org/009avj582

Department of Chemical Physiology and Biochemistry, Oregon Health and Science University

Portland

United States3

https://ror.org/009avj582

Parkinson Center of Oregon, Oregon Health and Science University

Portland

United States

Bellen

Hugo J

Reviewing Editor

https://ror.org/02pttbw34

Baylor College of Medicine

United StatesVijayRaghavan

Senior Editor

https://ror.org/03ht1xw27

National Centre for Biological Sciences, Tata Institute of Fundamental Research

India

†

Department of Biology, Stanford University, Stanford, United States

24042023

2023

e83545

1809202209042023

This manuscript was published as a preprint at bioRxiv.

05102022

2023

Villalobos-Cantor et al

http://creativecommons.org/licenses/by/4.0/

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Controlled protein synthesis is required to regulate gene expression and is often carried out in a cell type-specific manner. Protein synthesis is commonly measured by labeling the nascent proteome with amino acid analogs or isotope-containing amino acids. These methods have been difficult to implement in vivo as they require lengthy amino acid replacement procedures. O-propargyl-puromycin (OPP) is a puromycin analog that incorporates into nascent polypeptide chains. Through its terminal alkyne, OPP can be conjugated to a fluorophore-azide for directly visualizing nascent protein synthesis, or to a biotin-azide for capture and identification of newly-synthesized proteins. To achieve cell type-specific OPP incorporation, we developed phenylacetyl-OPP (PhAc-OPP), a puromycin analog harboring an enzyme-labile blocking group that can be removed by penicillin G acylase (PGA). Here, we show that cell type-specific PGA expression in Drosophila can be used to achieve OPP labeling of newly-synthesized proteins in targeted cell populations within the brain. Following a brief 2 hr incubation of intact brains with PhAc-OPP, we observe robust imaging and affinity purification of OPP-labeled nascent proteins in PGA-targeted cell populations. We apply this method to show a pronounced age-related decline in neuronal protein synthesis in the fly brain, demonstrating the capability of PhAc-OPP to quantitatively capture in vivo protein synthesis states. This method, which we call POPPi (PGA-dependent OPP incorporation), should be applicable for rapidly visualizing protein synthesis and identifying nascent proteins synthesized under diverse physiological and pathological conditions with cellular specificity in vivo.

proteomepuromycinaging

Research organismDrosophila melanogaster

OHSU Foundation

Martin

Ian

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Author impact statement

Newly-synthesized protein can be labeled with cellular specificity in Drosophila brain using the puromycin analog PhAc-OPP coupled to expression of the unblocking enzyme PGA in a tissue or cell type of interest.

Introduction

Controlled protein synthesis plays a fundamental role in orchestrating gene expression, and cellular protein amounts are thought to be primarily determined at the level of translation (Schwanhäusser et al., 2011). Translational control is integral to cellular development and homeostasis and becomes dysregulated in numerous disease states including cancer (Robichaud and Sonenberg, 2017), autism (Gkogkas et al., 2013), and neurodegeneration (Wiebe et al., 2020). Within a complex organ like the brain, the specialized and distinct properties of neuronal and glial subtypes arise from variable expression of many protein components which are subject to translational control (Doyle et al., 2008). Regulation of global protein synthesis as well as the modulated synthesis of specific proteins at the synapse is important in synaptic plasticity and memory formation (Sossin and Costa-Mattioli, 2019).

Despite advances in assessing the transcriptome with cellular resolution, mRNA levels are an imprecise surrogate for protein abundance, and methods to capture the nascent proteome of individual cell populations in vivo have lagged behind. Current methods employ indiscriminate protein synthesis labeling in all cells of a tissue followed by flow sorting of tagged cell suspensions from these tissues (Hidalgo San Jose and Signer, 2019) or regional microdissection (Griesser et al., 2020) and suffer from a lack of precision or substantial loss of protein. An alternative method for quantifying protein synthesis is through non-canonical amino acid (NCAA) protein labeling, using methionine analogs. This approach recently progressed toward cell-type specificity through the expression of engineered methionyl-tRNA synthetase (MetRS) (Alvarez-Castelao et al., 2017; Erdmann et al., 2015; Tanrikulu et al., 2009). Only mutant MetRS can charge methionyl-tRNA with azidonorleucine (ANL) which is amenable to protein capture by BONCAT (biorthogonal non-canonical amino acid tagging) and visualization by FUNCAT (fluorescent non-canonical amino acid tagging) (Alvarez-Castelao et al., 2017; Erdmann et al., 2015; Tanrikulu et al., 2009). Hence, nascent protein labeling is restricted to cells that express mutant MetRS. However, this labeling strategy requires extended dietary methionine depletion and lengthy ANL feeding in mice or 1–2d of ANL feeding in flies, and chronic feeding is associated with significant developmental toxicity and behavioral deficits (Alvarez-Castelao et al., 2017; Erdmann et al., 2015).

A potentially more efficient approach to protein synthesis labeling is through the use of puromycin analogs (Barrett et al., 2016; Liu et al., 2012). Puromycin is structurally similar to tyrosyl tRNA, yet its incorporation is not amino acid-specific, hence in contrast to NCAA, its incorporation into nascent proteins is not biased by their sequence or extent of methionine content. This facilitates more uniform incorporation into newly-synthesized proteins (Nathans, 1964), which is advantageous in the assessment of global protein synthesis. One caveat to this approach is that puromycin incorporation results in premature chain termination and therefore the production of truncated puromycylated proteins that, while still generally amenable to MS-based proteomic analysis, may be targeted for proteasome-mediated degradation. Addition of an O-propargyl group to puromycin allows visualization or capture of newly-synthesized protein via click-chemistry conjugation to a fluorophore-azide or a biotin-tagged azide, respectively, and has been successfully demonstrated in cultured cells (Liu et al., 2012) and in cells isolated from OP-puromycin (OPP)-injected animals (Hidalgo San Jose and Signer, 2019). We developed an analog of OPP called PhAc-OPP that harbors an enzyme-labile blocking group (Barrett et al., 2016). This blocking group renders OPP incapable of nascent protein incorporation until its removal by the E. coli enzyme PGA (Barrett et al., 2016). Hence, targeted expression of PGA can, in principle, be used to limit OPP proteome labeling to individual cell populations within animal tissues. To directly test this, we generated PGA-transgenic Drosophila and developed a method that we call POPPi for rapid, cell type-specific labeling of protein synthesis in intact fly brains. Here, we show that POPPi is a versatile labeling strategy that can achieve efficient visualization and identification of newly-synthesized proteins in a cell population of interest. Our approach enables cell-specific nascent proteome labeling from complex brain tissue within just a few hours, making it a powerful and efficient tool for examining the role of translational control in different physiological and pathological states.

Results

We previously demonstrated that neuronal PGA expression successfully converts PhAc-OPP to OPP, thus enabling OPP labeling of nascent proteins in cultured primary mouse neurons (Barrett et al., 2016; Figure 1—figure supplement 1A). Toward cell type-specific protein labeling in complex nervous system tissue in vivo, we generated a transgenic PGA fly line that can express FLAG-tagged PGA when crossed to any of the commonly available fly lines expressing a cell type-specific GAL4 driver of choice (Figure 1—figure supplement 1B). Following ubiquitous PGA expression, we assessed PGA levels in embryos and the brains of larvae, pupae, and adults. PGA expression is detectable in both developing and adult flies, with the highest expression levels seen in larval and pupal brains, followed by adult brains and embryos (Figure 1—figure supplement 1C). We reasoned that cell type-specific nascent protein labeling in the CNS might be efficiently achieved using intact Drosophila brain explants. Drosophila whole brains isolated and maintained ex vivo are remarkably stable, exhibiting sustained neuronal morphology and physiological properties for many hours (Ayaz et al., 2008; Brown et al., 2006; Essers et al., 2016; Gibbs and Truman, 1998; Gu and O’Dowd, 2006; Wang et al., 2003; Li et al., 2020; Lee et al., 2006). Fly brain explants have been used to study neuronal activity such as response to odor stimulation (Gu and O’Dowd, 2006; Wang et al., 2003), axon remodeling (Brown et al., 2006; Gibbs and Truman, 1998), neuronal wiring (Li et al., 2020), neural stem cell proliferation (Lee et al., 2006), and protein synthesis (Essers et al., 2016). To examine whether isolated adult fly brains exhibit stable protein synthesis, we generated fly brain preparations and assessed ³⁵S-methionine/cysteine incorporation levels over 8 hr. We observe no significant change in global protein synthesis rates over this time period (Figure 1A), suggesting that protein synthesis is stable in newly-isolated whole brain preparations and that these may therefore be suitable for capturing in vivo protein synthesis states.

Figure 1.O-propargyl-puromycin (OPP) labeling in <italic>Drosophila</italic> brain.

(A) Global protein synthesis (³⁵S-met/cys incorporation) is unaltered for 8 hr in newly-isolated w¹¹¹⁸ whole brain preparations (ANOVA, n.s. n=4–5 groups of 8–10 brains per timepoint). (B) Schematic illustrating cell type-specific protein synthesis labeling by PGA-dependent OPP incorporation (POPPi) for visualization or capture of the nascent proteome. Spatially targeted penicillin G acylase (PGA) expression catalyzes phenylacetyl-OPP (PhAc-OPP) blocking group removal, liberating OPP for incorporation into nascent polypeptide chains (NPC). OP-puromycylated proteins can be visualized by confocal microscopy following conjugation to a fluorescent-azide or enriched following conjugation to desthiobiotin-azide. (C) Newly-synthesized protein (from w¹¹¹⁸ brains) visualized by AF488-azide after OPP incubation but not without OPP (ctrl) and diminished signal with cycloheximide (CHX). Labeling appears stronger in cell bodies within the cell cortex (C) than in the neuropil (n). Higher magnification (63 x) images are from the cell cortex. Scale bars are 60 μM (or 10 μM for 63 x). (D) Quantitation of (C) revealing a significant effect of the treatment group (ANOVA, p<0.0001, Bonferroni post-test, **p<0.01, ****p<0.0001, n=8–11 brains/group). (E) In-gel fluorescence of brain protein extracts, ctrl is no OPP. Data are mean ± SEM. Schematic in B created on Biorender. See also Figure 1—figure supplements 1 and 2.

Figure 1—source data 1.Source gel images for <xref ref-type="fig" rid="fig1">Figure 1E</xref>.

Figure 1—figure supplement 1.Penicillin G acylase (PGA)-dependent conversion of phenylacetyl-OPP (PhAc-OPP) to O-propargyl-puromycin (OPP) in <italic>Drosophila</italic>.

(A) Scheme illustrating the conversion of PhAc-OPP to OPP by penicillin G acylase (PGA). PGA catalyzes the removal of the phenylacetyl blocking group and the carbamate spacer then undergoes spontaneous fragmentation to generate OPP. (B) Scheme illustrating expression of N-terminally FLAG-tagged PGA under a cell-specific driver of choice using the binary GAL4/UAS system. (C) PGA expression levels within whole embryos or the brains of L3 larvae, pupae or adult flies expressing PGA via the ubiquitous Actin5C-GAL4 driver. Asterisk, non-specific band. Both loading controls (β-actin and GAPDH) are divergent in expression, size, and/or number of bands between embryos, larvae, pupae, and adults, hence a Ponceau stain is shown for protein loading. Illustration in B created on Biorender.

Figure 1—figure supplement 1—source data 1.Source western blots for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>.

2016

American Chemical Society

Panel A is reprinted (adapted) with permission from Scheme 1 of Barrett et al., 2016. It is not covered by the CC-BY 4.0 license and further reproduction of this panel would need permission from the copyright holder.

Figure 1—figure supplement 2.O-propargyl-puromycin (OPP) nascent proteome labeling is concentration and time-dependent.

(A) Significant effect of OPP concentration on OPP labeling in standard laboratory control flies (w¹¹¹⁸, ANOVA, p<0.0001, Bonferroni post-tests, ****p<0.0001, n=11–14 brains/group). Labeling time was 2 hr. (B) Significant effect of labeling time on OPP labeling in w¹¹¹⁸ flies (ANOVA, Bonferroni post-tests, ****p<0.0001, n=9–10 brains/group). 50 μM OPP was used. Data are mean ± SEM.

<italic>Drosophila</italic> brain nascent proteome labeling with OPP

Two major goals for cell-specific protein synthesis labeling are the visualization and identification of nascent proteomes in a cell type of interest. We hypothesized that this could be accomplished in Drosophila brain through OPP labeling of nascent polypeptide chains (NPC) followed by click-chemistry conjugation to either a fluorophore-azide for protein visualization or a biotin-azide for protein capture (schematic in Figure 1B). We first assessed whether unblocked OPP can label newly-synthesized proteins in Drosophila brain explants. Widespread OPP incorporation into newly-synthesized protein is clearly visible across the adult brain when coupled to the fluorophore-azide AF488-azide for detection (Figure 1C). The extent of incorporation is dependent on OPP concentration and slightly on incubation time (Figure 1—figure supplement 2) and is blocked by the protein synthesis inhibitor cycloheximide (Figure 1C and D), indicating that it is protein synthesis-dependent. Labeling is most prominently seen in the cell cortex, the location of cell bodies within the fly brain, consistent with the majority of protein synthesis occurring within the cell soma (Figure 1C). Theoretically, the protein synthesis imaged through this approach could represent OPP incorporation into a wide array of translating proteins or be restricted to a few highly-expressed proteins. In-gel fluorescence assessment of electrophoretically-separated brain extracts reveals that OPP-labeled proteins span the whole molecular weight range, while a minor degree of non-specific background AF488-azide incorporation is seen in the absence of OPP (Figure 1E). This finding suggests that OPP is efficiently and unbiasedly incorporated into a broad set of proteins, which is also consistent with prior studies from OPP labeling of cultured human cells (Forester et al., 2018).

Rapid cell type-specific protein synthesis labeling with PhAc-OPP

We next assessed if targeted PGA expression can promote PhAc-OPP unblocking and OPP labeling of newly-synthesized proteins in cell populations of interest. We expressed PGA pan-neuronally in Drosophila brain using the elavC155-GAL4 driver, which we confirmed by immunoblot (Figure 2—figure supplement 1A) and then treated freshly-isolated brain explants with PhAc-OPP for 2 hr. Robust neuronal protein synthesis labeling is seen following PhAc-OPP treatment, but not in the absence of PhAc-OPP (Figure 2A) or in PhAc-OPP treated brains in the absence of GAL4-driven PGA expression (Figure 2—figure supplement 1B), suggesting that PhAc-OPP is not substantially uncaged in the absence of PGA expression and therefore that it can be reliably used to label newly-synthesized protein in targeted cell populations expressing PGA. The extent of labeling is time-dependent, although appears to be maximal at around 2 hr (Figure 2B). This is consistent with a prior study of OPP labeling in cells (Liu et al., 2012), and with a scenario that OPP-peptide conjugates eventually undergo turnover. Cellular AF488-azide signal is not uniform across the cell cortex (Figure 2A), which is consistent with cell-to-cell variability in PGA expression observed in FLAG immunostained brains (Figure 2—figure supplement 1C). When PGA expression was restricted to dopamine neurons using TH-GAL4, newly-synthesized proteins are clearly visible in the soma of dopamine neurons within intact brain explants briefly treated with PhAc-OPP, but not in the surrounding tissue (Figure 2C). PGA expression targeted to glia via repo-GAL4, also confirmed via immunoblot (Figure 2—figure supplement 1A), results in visible nascent protein labeling in glial cells (co-labeled with mCherry) upon brief PhAc-OPP treatment, but not in the absence of PhAc-OPP (Figure 2D). Hence, POPPi can efficiently label newly-synthesized proteins in neuronal and glial cell populations within the fly brain.

Figure 2.Cell type-specific protein synthesis labeling with phenylacetyl-OPP (PhAc-OPP).

(A) Brains from elavC155-GAL4;UAS-PGA flies incubated with PhAc-OPP show widespread protein synthesis labeling in neurons, labeled with Elav neuronal nucleus marker. No labeling in vehicle-treated brains (ctrl). Labeling appears highest in the cell bodies of the cell cortex (c) and minimal in the neuropil (n). (B) AF488-azide quantitation after varying durations of PhAc-OPP labeling in pan-neuronal penicillin G acylase (PGA) expressing flies. Significant effect of PhAc-OPP incubation time on labeling (ANOVA, Bonferroni post-test, ****p<0.0001, n=10–12 brains per group). (C) Protein synthesis labeling in isolated brains from flies expressing PGA in dopamine neurons (TH-GAL4/UAS-PGA). TH, tyrosine hydroxylase. (D) Protein synthesis labeling following pan-glial expression of PGA and a membrane-tethered mCherry reporter (Repo-GAL4, UAS-mCD8::mCherry/UAS-PGA). Glial cell bodies and neuron-encapsulating surface areas are mCherry-positive. Arrows indicate glial cell bodies positive for both mCherry and AF488, indicative of glial protein synthesis labeling. Controls in A, C, and D are vehicle-treated brains. (E) Significant effect of 200 μM PhAc-OPP on global protein synthesis in flies expressing PGA ubiquitously via Actin5C-GAL4 (ANOVA, Bonferroni post-test, **p<0.01, n=3 groups of 8–10 brains/group). (F) No significant effect of PhAc-OPP on total protein ubiquitination in flies expressing PGA ubiquitously, quantified in G (ANOVA, n=3 groups of 20 brains/group). Data are mean ± SEM. See also Figure 2—figure supplement 1.

Figure 2—source data 1.Source western blots for <xref ref-type="fig" rid="fig2">Figure 2F</xref>.

Figure 2—figure supplement 1.Cell-specific labeling via penicillin G acylase (PGA) expression.

(A) FLAG-PGA expression via elav^C155-GAL4 or repo-GAL4 in whole brain extracts. (B) No phenylacetyl-OPP (PhAC-OPP) labeling in UAS-PGA/+ control fly brains lacking the elav^C155-GAL4 driver, incubated with PhAc-OPP. c, cell cortex showing positive immunostaining for the neuronal nuclear protein Elav. n, neuropil. (C) FLAG (L5 clone) immunostaining for PGA expression pattern in elav^C155-GAL4>UAS PGA fly brain (PGA). Control is elav^C155-GAL4/+.

Figure 2—figure supplement 1—source data 1.Source western blots for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>.

Since OPP incorporation into NPC results in peptide chain termination, we queried whether PhAc-OPP treatment diminishes overall protein synthesis rates. To assess this, we performed ³⁵S-methionine labeling in parallel to PhAc-OPP treatment of brain explants expressing PGA ubiquitously. We found that PhAc-OPP causes a dose-dependent inhibition of global protein synthesis rates but that this inhibition was minimal up to 100 μM PhAc-OPP (Figure 2E) which is the standard concentration used in our labeling experiments. A significant disruption of protein synthesis is only seen above 100 μM PhAc-OPP (Figure 2E). Additionally, protein ubiquitination levels are not affected by incubating brains in up to 100 μM PhAc-OPP for 2 hr (Figure 2F and G), consistent with PhAc-OPP not having a major impact on protein turnover under these conditions.

While our primary focus was on labeling brain cell populations, we probed whether PhAc-OPP can penetrate other dissected tissues besides the brain. Rather than express PGA in several individual tissues separately, we drove ubiquitous PGA expression via Actin5C-Gal4 and incubated inverted L3 larvae (which exhibit robust PGA expression (Figure 1—figure supplement 1)) in PhAc-OPP, followed by AF488-azide under the same conditions used for labeling and visualizing protein synthesis in isolated brains. We then dissected the fat body, trachea, muscle, and salivary gland for imaging. As seen in the brain, newly-synthesized protein can be clearly visualized in all larval bodily tissues examined (Figure 3), suggesting that PhAc-OPP can readily penetrate a variety of tissues besides the brain.

Figure 3.Protein synthesis labeling in other major tissues using phenylacetyl-OPP (PhAc-OPP).

Tissues from L3 larvae incubated with PhAc-OPP show widespread protein synthesis labeling, visualized following O-propargyl-puromycin (OPP) conjugation to AF488-azide. All larvae expressed penicillin G acylase (PGA) via Actin5C-Gal4.

Rapid cell type-specific nascent proteome capture with PhAc-OPP

As observed upon treating brain explants with OPP (Figure 1E), we find that PGA-dependent unblocking of PhAc-OPP in all neurons or in all glia of adult fly brains gives rise to OPP-labeled proteins that span a wide molecular weight range consistent with broad incorporation into the nascent proteome (Figure 4A and D). Pan-neuronal PGA expression was coupled to PhAc-OPP treatment and brain lysates were click conjugated to desthiobiotin azide for affinity purification of the neuronal proteome using neutravidin beads. Detection of total biotin-tagged protein with anti-biotin reveals robust enrichment of OPP-labeled protein in pulldown fractions relative to input (whole lysates) (Figure 4B). In support of widespread incorporation into NPC, we were able to label specific neuronal proteins of interest. Three crucial synaptic proteins involved in neurotransmitter release, namely Bruchpilot (ERC2 ortholog), Synapsin and Syntaxin, are all substantially enriched in the OPP-labeled neuronal proteome following affinity purification (Figure 4C). Similarly, glial PGA expression coupled to PhAc-OPP incubation and affinity purification with desthiobiotin azide yields strong enrichment of desthiobiotin-tagged OPP-labeled protein (Figure 4E) and of the glial-specific protein Draper (ortholog of the mammalian engulfment receptor MEGF10) (Figure 4F). Conversely, the neuronal SNARE complex protein Syntaxin is not enriched upon pan-glial PGA expression, supporting the conclusion that proteome labeling is restricted to the cell population expressing PGA.

Figure 4.Capture and identification of newly-synthesized proteins from neurons and glial.

(A) In-gel AF488 fluorescence across a broad range of proteins in fly brain extracts expressing penicillin G acylase (PGA) pan-neuronally and following incubation with phenylacetyl-OPP (PhAc-OPP). Controls groups are no PGA expression (with PhAc-OPP) or no PhAc-OPP (with PGA expression). (B) Detection of total desthiobiotin-tagged protein in brain lysates (input) or pulldown fractions (eluate) following pan-neuronal PGA expression, PhAc-OPP incubation, conjugation of OPP-labeled protein to desthiobiotin azide and neutravidin bead pulldown. A strong background band of unknown endogenously biotinylated protein is observed between 100–150 kDa. (C) Enrichment of neuronal proteins Brp, Synapsin, and Syntaxin following neutravidin pulldown of desthiobiotin-tagged protein from pan-neuronal elav-GAL4/UAS-PGA brain extracts. (D) Pan-glial PGA expression (Repo-GAL4/UAS-PGA) promotes broad O-propargyl-puromycin (OPP) protein labeling in brain extracts following PhAc-OPP incubation but not vehicle control. Enrichment of total desthiobiotin-tagged protein seen following neutravidin bead pulldown of the glial proteome, detected with anti-biotin (D) and enrichment of the glial-specific protein Draper (with apparent mol. weight shift between input and eluate) from Repo-GAL4/UAS-PGA extracts, but not the neuron-specific protein Syntaxin. Data are representative of three independent experiments.

Figure 4—source data 1.Source western blots for <xref ref-type="fig" rid="fig4">Figure 4</xref>.

No effect of cell type-specific PGA expression on adult fitness or survival

Having found that PGA expression coupled to PhAc-OPP incubation can be used to visualize and capture the nascent proteome in a cell type-specific manner, we sought to determine whether PGA expression in flies affects their development, function, or survival. Toward this goal, we crossed UAS-PGA flies to pan-neuronal, pan-glial, or ubiquitous GAL4 driver strains and assessed the resulting progeny. Startle-induced negative geotaxis behavior is dependent on a functionally-intact nervous system and declines progressively with age in flies (Gargano et al., 2005; Martin and Grotewiel, 2006). Neither pan-neuronal nor pan-glial PGA expression affects negative geotaxis performance across age (Figure 5A), while ubiquitous PGA expression causes a pronounced deficit in 3-week-old flies but not at a more advanced age in 6-week-old flies (Figure 5B). In accordance with this, ubiquitous PGA expression impairs adult survival, resulting in a ~20% decrease in median lifespan (Figure 5D and Table 1), whereas no lifespan shortening is seen following pan-neuronal or pan-glial PGA expression (Figure 5C and Table 2). In fact, lifespan appears to be slightly extended by pan-glial PGA (Figure 5C and Table 2). Besides its negative effect on function and survival, ubiquitous PGA expression is also associated with major larval lethality suggesting that development is perturbed, while larval and pupal survival are unaffected by pan-neuronal or pan-glial PGA expression (Figure 5—figure supplement 1) and eclosion occurs at the expected Mendelian frequency. Collectively, these data suggest that PGA expression within the brain is well tolerated across the fly lifespan, and raise the possibility that PGA expression in an unknown tissue outside of the nervous system has a negative impact on development, function, and adult survival.

Figure 5.No deleterious effect of cell-specific penicillin G acylase (PGA) expression.

(A) No significant effect of pan-neuronal or pan-glial PGA expression on negative geotaxis behavior at 3 and 6 weeks of age (two-way ANOVA for the effect of age (p<0.0001) and genotype, (n.s.), n=3–6 groups of 25 flies/genotype/age). (B) Significant effect of ubiquitous PGA expression on negative geotaxis behavior at 3 weeks of age (two-way ANOVA for the effect of age (p<0.0001) and genotype (p<0.0001), Bonferroni post-test, ****p<0.0001, n=5–6 groups of 25 flies/genotype/age). (C) Survival is slightly extended upon pan-neuronal or pan-glial PGA expression. (D) Significant effect of ubiquitous PGA expression on survival. For C and D, see Tables 1 and 2 for experimental n, lifespan metrics, and log-rank (Mantel-Cox) comparison results. Data are mean ± SEM. See also Figure 5—figure supplement 1.

Figure 5—figure supplement 1.Larval lethality following ubiquitous penicillin G acylase (PGA) expression.

Numbers in parentheses are the number of flies tested.

Table 1.Ubiquitous penicillin G acylase (PGA) expression effect on survival.

Genotype	N	Median lifespan (d)	Mean lifespan (d)	Log-rank (vs PGA/+ctrl)
UAS-PGA/+	142	54	53.1	-
Actin5C-GAL4/UAS-PGA	110	44	45.6	.006

Table 2.Neuronal and glial penicillin G acylase (PGA) expression effect on survival.

Genotype	N	Median lifespan (d)	Mean lifespan (d)	Log-rank (vs. PGA/+ctrl)
UAS-PGA/+	152	52	50.8	-
elav^C155-GAL4/UAS-PGA	147	52	52.1	0.002
Repo-GAL4/UAS-PGA	112	63	58.4	<0.001

Brain explant labeling can capture in vivo protein synthesis states

In order to measure cell type-specific protein synthesis under various physiological or pathological conditions, it is important to know whether POPPi can be used to capture in vivo protein synthesis states in newly-isolated brains. To address this question, we examined neuronal protein synthesis labeling in the brains of young and aged flies. It is well established that a widespread age-related decline in protein synthesis occurs in the tissues of numerous organisms including Drosophila, when measured across the whole body (Fleming et al., 1986) or in heads (Yang et al., 2019), and that the decline is due to reduced mRNA translation as well as transcript abundance. To determine whether this same decline is seen specifically in the brains of aging flies, we measured global protein synthesis in young (4-day-old) and aged (21-day-old) wild-type fly brains and observe a substantial decrease in radiolabeled protein from aged fly brain, indicative of decreased protein synthesis (Figure 6A). Next, using POPPi in which PGA was expressed pan-neuronally, we were able to observe a decline in neuron-specific bulk protein synthesis in the aging fly brain (Figure 6B and C). Strikingly, neuronal protein synthesis was reduced by almost 50% in 3-week-old elavC155-GAL4/UAS-PGA flies relative to young (4-day-old) flies of the same genotype (Figure 6B and C). Measurement of PGA expression confirmed that this age-related decline in protein labeling was not due to a loss of PGA expression in aged flies (Figure 6D). These data support the conclusion that PGA expression coupled with PhAc-OPP incubation can be used to achieve a quantitative assessment of protein synthesis and that an age-dependent decline in protein synthesis can be effectively captured by this method.

Figure 6.Age-dependent decline in neuronal protein synthesis rate.

(A) Significant age-related decline in whole brain protein synthesis in aging flies, measured by ³⁵S-met/cys labeling (Student’s t-test, ***p<0.001, n=4 groups of eight brains/age). (B) Nascent proteome labeling in young (4-day-old) vs. aged (21-day-old) fly brains expressing pan-neuronal penicillin G acylase (PGA) following phenylacetyl-OPP (PhAc-OPP) incubation. (C) The significant effect of aging on protein synthesis (Student’s t-test, p<0.0001, n=10–12 brains/group). Fluorescence signals at each age was derived by subtracting from the mean of a no-label control brain population tested in parallel. (D) PGA expression is comparable in 4- and 21-day-old elavC155-GAL4/UAS-PGA fly brains. Data are mean ± SEM.

Figure 6—source data 1.Source western blots for <xref ref-type="fig" rid="fig6">Figure 6D</xref>.

Protein synthesis labeling via PhAc-OPP dietary intake

While incubating brain explants in PhAc-OPP allows rapid protein synthesis labeling in cell populations of interest, we queried whether PhAc-OPP ingested in food can penetrate the brain and label newly-synthesized protein. To assess the feasibility of this approach, we exposed pan-neuronal PGA-expressing flies to various concentrations of PhAc-OPP in sugar-yeast extract food medium for 48 hr then determined whether OPP-labeled nascent protein can be visualized following AF488-azide conjugation. We observe concentration-dependent labeling with PhAc-OPP and that AF488-azide signal becomes significantly higher than background at concentrations ≥1 mM (Figure 7A and B). Importantly, flies appear to consume 4 mM PhAc-OPP-containing food in similar quantities to that of control food (Figure 7C), suggesting that food consumption is not significantly impaired by the presence of PhAc-OPP, even at the highest dose tested. These results suggest that PhAc-OPP administered dietarily can penetrate the brain at levels sufficient to obtain detectable albeit subtle nascent protein labeling.

Figure 7.Protein synthesis labeling via dietary phenylacetyl-OPP (PhAc-OPP) administration.

(A) Subtle detection of protein synthesis labeling by AF488-azide following exposure of pan-neuronal penicillin G acylase (PGA)-expressing flies to dietary PhAc-OPP (4 mM) for 48 hr. Brains were counterstained with Dylight Phalloidin-650. (B) AF488-azide quantitation after varying concentrations of PhAc-OPP exposure in pan-neuronal PGA-expressing flies. Significant effect of PhAc-OPP concentration on labeling (ANOVA, Bonferroni post-test, ***p<0.001, ****p<0.0001, n=12–17 brains per group). (C) No significant effect of PhAc-OPP (4 mM) on food intake levels over 4 hr (ANOVA, Bonferroni post-test, ns, n=4 groups of eight flies per condition).

Discussion

POPPi is a new method to rapidly visualize and capture cell-specific nascent proteomes in whole Drosophila brains. This method extends the demonstrated capability of PGA-dependent OPP labeling in cultured neurons (Barrett et al., 2016) to proteome labeling within complex nervous system tissue. OPP efficiently labels nascent proteomes within the fly brain and this is substantially blocked by the protein synthesis inhibitor cycloheximide (Figure 1C and D), indicating that de novo protein synthesis is key for labeling to occur. We show that our strategy is versatile and can be used to visualize nascent protein synthesis across all CNS neurons, specific to a small population of dopaminergic neurons or limited to glia (Figure 2). We also demonstrate that POPPi can be used to capture neuronal or glial proteomes and enrich proteins of interest within those cell populations (Figure 4). Global protein synthesis is stable for at least 8 hr in isolated whole brain preparations (Figure 1A), supporting an ability to capture in vivo protein synthesis states using this approach. Consistent with this, we were able to detect an age-related decline in bulk neuronal protein synthesis in the fly brain using PhAc-OPP (Figure 6). Future efforts will be focused on coupling proteome enrichment to mass spectrometry to interrogate the effects of physiological or pathological stimuli on the proteome at the level of individual proteins.

Spatially-resolved proteomic studies have lagged behind transcriptomic studies in part because issues with limited RNA starting material can be overcome by PCR amplification of cDNA, while no equivalent exists for protein. Nonetheless, flies can be rapidly bred to vast numbers and we anticipate that the facile scalability of Drosophila can be leveraged for proteomic studies that focus on small-cell populations. PGA transgenic flies are well-suited for CNS proteomic studies because PGA is robustly expressed in adult, larval, and pupal brains (Figure 1—figure supplement 1) as well as via neuronal and glial GAL4 drivers (Figure 2—figure supplement 1). Accordingly, while our efforts centered on characterizing proteome labeling within the adult CNS in this study, we anticipate that our chemical genetic approach should be applicable to examining CNS proteomes during fly development. Drosophila has been widely used in genetic studies of nervous system development (Jan and Jan, 2010), function (Noyes et al., 2021), aging (Piper and Partridge, 2018), and disease (Şentürk and Bellen, 2018). Major insights from these studies highlight strong conservation with mammalian biology and have spurred diverse proteomic analyses of gene expression in the fly nervous system (Li et al., 2020; Owald et al., 2010; Mangleburg et al., 2020; Wang et al., 2020) and interest in using flies to model the role of translational regulation in nervous system disease (Greenblatt and Spradling, 2018; Lu et al., 2014; Mizielinska et al., 2014). In addition to the work on diseases such as fragile X syndrome (Greenblatt and Spradling, 2018), frontotemporal dementia (Mizielinska et al., 2014), and diseases associated with aminoacyl-tRNA synthetase mutations (Lu et al., 2014) by others, we recently showed how aberrant translation contributes to neurodegenerative phenotypes caused by the common Parkinson’s disease-causing mutation LRRK2 G2019S in Drosophila and iPSC-derived dopamine neurons (Martin et al., 2014a; Martin et al., 2014b; Kim et al., 2020), adding to emerging evidence of translational dysregulation in models of Parkinson’s disease (Martin, 2016). Hence, we foresee many opportunities for PGA-expressing flies to generate insight into nervous system function and disease through cell type-specific proteomic studies. Our study builds on previous findings that OP-puromycin can successfully label cellular protein synthesis when applied to cultured mammalian cells (Liu et al., 2012; Forester et al., 2018) and from bone marrow cells when administered by i.p. injection to mice (Hidalgo San Jose and Signer, 2019). These findings indicate that OP-puromycin can readily penetrate cell membranes and is also able to permeate tissues. PhAc-OPP differs from OP-puromycin by the addition of a phenylacetyl group and N- (benzyloxy) carbamate spacer which renders PhAc-OPP more hydrophobic than OP-puromycin. This is anticipated to enhance the ability of PhAc-OPP to penetrate cell membranes by diffusion, while diluted concentrations can still be prepared in an aqueous solution for tissue incubation (see Materials and methods).

One potential concern surrounding the use of puromycin labeling is that its incorporation into NPC causes chain termination, therefore, at high-enough doses, it could impede cellular protein synthesis (Liu et al., 2012). This may be circumvented by finding an optimal concentration of puromycin (or analog) which permits sufficient labeling for detection while having minimal impact on total protein synthesis. We assessed this in Drosophila brains and found that 100 μM PhAc-OPP allowed us to obtain robust and rapid proteome labeling while not observing significant deficits in global protein synthesis that were seen at a higher concentration (Figure 2E). Another consequence of chain termination when occurring prematurely is the production of truncated protein. Interestingly, we were only able to detect what appears to be full-length protein by western blot following neutravidin enrichment and blotting for individual proteins (Figure 4C and F). While truncated proteins may be targeted for degradation and thus depleted from the lysate pool, another simple explanation for this observation is that all antibodies we used which have reported epitopes bind to C-terminal epitopes. These would be missing in truncated proteins, thus precluding their detection using these antibodies.

We assessed whether ectopic PGA expression in fly cell populations perturbs organism development, function, or survival. In contrast to ubiquitous PGA expression, neither neuronal nor glial PGA expression has any discernible negative impact on development, adult function, or survival (Figure 5 and Figure 5—figure supplement 1). Hence, when expressed in individual nervous system cell populations, PGA expression seems to be well tolerated. This may provide an advantage over existing NCAA-based cell-specific labeling strategies, where chronic ANL feeding to flies prior to proteomic assessment significantly impairs fly eclosion as well as negative geotaxis behavior in adults (Erdmann et al., 2015). There are additional concerns over how chronic NCAA feeding in this approach might affect protein abundance and overall proteome makeup. For example, the replacement of methionine with the NCAA L-azidohomoalanine (AHA) was seen to cause substantial changes in the abundance of numerous proteins in HeLa cells while AHA incorporation into the developing mouse proteome results in altered expression of about 10% of proteins (Bagert et al., 2014; Calve et al., 2016). It is also currently unclear whether long-term NCAA administration disrupts eukaryotic metabolism given that AHA and L-homopropargylglycine (HPG) were found to alter global metabolism in E. coli (Steward et al., 2020). Taken together with the fact that NCAA labeling requires extended dietary methionine depletion, lengthy feeding with amino acid analogs (Alvarez-Castelao et al., 2017; Erdmann et al., 2015), and that NCAA are not incorporated equally across the proteome, there are significant caveats associated with this labeling strategy that can be avoided using POPPi.

While here we focused on protein synthesis labeling in intact isolated brains, this method should in theory be amenable to proteome labeling in tissues throughout the body, wherever PGA can be adequately expressed. In support of this, we obtained preliminary evidence demonstrating the ability of PhAc-OPP to penetrate and label several bodily tissues (fat body, trachea, muscle, and salivary gland) under the same conditions used for protein synthesis labeling in the brain (Figure 3). We also obtained preliminary evidence that PhAc-OPP can penetrate the brain when administered dietarily to intact flies (Figure 7). Based on the magnitude of AF488-azide labeling, ingestion at the PhAc-OPP concentration range tested yields lower nascent protein labeling than we were able to achieve in brain explants at much lower concentrations, which we speculate may be due to comparatively lower levels of PhAc-OPP reaching the brain. Future studies will address whether labeling in other tissues can be achieved via dietary PhAc-OPP intake, as this approach may be crucial when tissues cannot be isolated and effectively sustained. Despite this uncertainty, the ability to rapidly quantify protein synthesis in cell populations within the CNS established here opens up many possibilities to address important questions pertaining to nervous system development, function, aging, and disease.

Current proteomic approaches for measuring protein synthesis harbor strengths and weaknesses compared to transcriptomic approaches. Ribosomal profiling and other ribosome capture methods such as TRAP measure ribosomal density on a given transcript which provides a proxy for the rate of protein synthesis but not an actual measure of protein product. Ribosomal profiling has provided important insights into mechanisms of translational control, yet, there are some weaknesses to the method (Brar and Weissman, 2015). Perhaps most importantly, inferring protein synthesis rates from a single snapshot of average ribosomal occupancy on a given mRNA is based on assumptions that all ribosomes complete translation, and are not subject to regulated translational pausing or abortion at the time of capture or at any time prior to finishing translation. Additionally, the method itself may miss ribosomal footprints if nuclease digestion is incomplete, and give rise to false readouts of translation from contaminating non-coding RNA fragments. In contrast, assessing translation at the level of synthesized protein, e.g., through quantitative proteomics, should avoid errors associated with inferring protein synthesis rates from ribosomal occupancy, with the caveat that higher sensitivity limits relative to transcriptomic approaches may make transcriptomics the method of choice when starting material is low. We believe a potential major advantage of POPPi over existing methods for measuring cell type-specific protein synthesis is its efficiency, particularly for visualizing protein synthesis – PhAc-OPP labeling coupled to AF488-azide conjugation can be completed within a few hours (see Methods). Future work will seek to understand the full capabilities and limitations of POPPi, e.g., for profiling rare cell populations in the brain.

In summary, we provide a new labeling method for rapidly visualizing, capturing, and quantifying cell type-specific nascent proteomes within the Drosophila brain. We believe this method will be a powerful tool for studying the role of the proteome and translational control in nervous system function with cellular resolution.

Materials and methods

Key resources table

Reagent type (species) or resource	Designation	Source or reference	Identifiers	Additional information
Genetic reagent (D. melanogaster)	UAS-PGA	This paper		FLAG-tagged penicillin G acylase under UAS control
Genetic reagent (D. melanogaster)	Actin5C-Gal4	Bloomington Drosophila Stock Center	BDSC:25374FLYB:FBti0127834; RRID:BDSC_25374	FlyBase symbol: P{Act5C-GAL4-w}E1
Genetic reagent (D. melanogaster)	Elav(C155)-Gal4	Bloomington Drosophila Stock Center	BDSC:458FLYB:FBti0002575;RRID:BDSC_458	FlyBasesymbol: P{GawB}elav[C155]
Genetic reagent (D. melanogaster)	Repo-Gal4	Bloomington Drosophila Stock Center	BDSC:7415FLYB:FBti0018692RRID:BDSC_7415	FlyBasesymbol: P{GAL4}repo
Genetic reagent (D. melanogaster)	TH-Gal4	Bloomington Drosophila Stock Center	BDSC:8848FLYB:FBti0072936RRID:BDSC_8848	FlyBase symbol:P{ple-GAL4.F}3
Biological sample (D. melanogaster)	Drosophila brain explants	This paper		Freshly isolated from various D. melanogaster genotypes
Antibody	Anti-Biotin rabbit polyclonal	Bethyl Laboratories Inc.	Cat: A150109A	1:1000
Antibody	Anti-Brp (nc82) mouse monoclonal	DSHB	Cat: nc82	1:50
Antibody	Anti-Synapsin (3C11) mouse monoclonal	DSHB	Cat: 3C11	1:500
Antibody	Anti-Syntaxin (8C3) mouse monoclonal	DSHB	Cat: 8C3	1:500
Antibody	Anti-Draper 8A1 mouse monoclonal	DSHB	Cat: 8A1	1:400
Antibody	Anti-Draper 5D14 mouse monoclonal	DSHB	Cat: 5D14	1:400
Antibody	Anti-Elav 9F8A9 mouse monoclonal	DSHB	Cat: 9F8A9	1:100
Antibody	Anti-FLAG (M2) mouse monoclonal	Millipore Sigma	Cat: F1804	1:500
Antibody	Anti-FLAG (L5) mouse monoclonal	Novus Biologicals	Cat: NBP1-06712	1:1000
Antibody	Anti-Actin-HRP (AC15) mouse monoclonal	Millipore Sigma	Cat: A3854	1:2000
Antibody	Anti-GAPDH (GA1R) mouse monoclonal	ThermoFisher	Cat:MA5-15738	1:10,000
Antibody	Anti-TH mouse monoclonal	Immunostar	Cat: 22941	1:1000
Antibody	Anti-Ubiquitin (P4D1) rabbit monoclonal	Cell Signaling Technology	Cat: 3936	1:1000
Commercial assay or kit	Click-iT Plus OPP Alexa Fluor 488 Protein Synthesis Assay Kit	ThermoFisher	Cat: C10456
Chemical compound, drug	PhAc-OPP	This paper and reference (Barrett et al., 2016)		See reference (Barrett et al., 2016) for chemical synthesis details
Chemical compound, drug	Desthiobiotin azide	Click Chemistry Tools	Cat: 50-210-7822
Chemical compound, drug	TBTA (Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine)	MilliporeSigma	Cat:678937
Chemical compound, drug	Cu(I)Br	MilliporeSigma	Cat: 61163
Chemical compound, drug	Neutravidin agarose	Thermo Scientific	Cat: P129204
Chemical compound, drug	Colloidal blue staining kit	ThermoFisher	Cat: LC6025

<italic>Drosophila</italic> stocks and culture

PGA-expressing flies were generated by subcloning N-terminal FLAG-tagged full-length PGA cDNA (gift of C. Doe) into the fly transformation vector pUAST between KpnI and EcoRI restriction sites. After sequence verification and successful construct expression following transient transfection of UAS-PGA and GAL4 into Drosophila S2 cells, the construct was microinjected into w¹¹¹⁸ fly embryos (Bestgene, Inc). Transgenic FLAG-PGA expression was confirmed by FLAG Western blotting of adult head extracts after crossing all generated UAS-PGA lines to Actin5C-GAL4 (ubiquitous), elavC155-GAL4 (pan-neuronal), and repo-GAL4 (pan-glial). The following strongest-expressing lines were used throughout the study: UAS-PGA-1 for ubiquitous expression and UAS-PGA-3 for neuronal or glial expression. The repo-GAL4, UAS-mCD8::mCherry recombinant line was a gift from M. Freeman and all other lines were obtained from the Bloomington Drosophila Stock Center: TH-GAL4 (line 8848); elav^C155-GAL4 (line 458); repo-GAL4 (line 7415); Act5c-GAL4 (line 25374). All flies were reared and aged at 25 °C/60% relative humidity under a 12 hr light-dark cycle on a standard food medium.

PhAc-OPP synthesis and preparation

PhAc-OPP was synthesized from chemical precursors, analyzed by proton NMR, analytical thin-layer chromatography, and purified by flash chromatography as previously described (Barrett et al., 2016).

To prepare PhAc-OPP for tissue incubations, a stock solution (20 mM dissolved in DMSO) was diluted to 100 μM in Schneider’s Drosophila medium (with L-glutamine and sodium bicarbonate), bath sonicated for 6 min, vortexed continuously for 30 s prior to adding the proteasomal inhibitor MG132 (60 μM) and then kept at RT until use. To prepare PhAc-OPP for ingestion in a small food volume, 2 X the final desired concentration of PhAc-OPP was dissolved in 0.25 ml of distilled water via several brief tip sonication pulses, briefly heated to 55 °C then mixed thoroughly in a 1:1 volumetric ratio with 0.25 ml of 2 X sugar-yeast food solution (3% agar/10% sucrose/20% yeast extract) previously heated to 100 °C and cooled to 55 °C. After the food had solidifed, the microfuge tube containing the food was cut just above the food surface and inserted upright into a cotton plug placed at the bottom of a shell vial. Flies were transferred to the vial and kept in a humidified chamber throughout feeding for the indicated durations.

Adult brain preparations and <sup>35</sup>S-methionine/cysteine assessment of de novo protein synthesis

Adult brains were isolated and maintained for protein synthesis assessment in Schneider’s Drosophila medium (formulated for Drosophila cells and tissues and supplemented with L-glutamine and sodium bicarbonate), based on previously reported methods (Ayaz et al., 2008; Gibbs and Truman, 1998). Prior long-term culture of Drosophila CNS explants has often included the addition of insulin and/or serum to the culture medium (Ayaz et al., 2008; Gibbs and Truman, 1998). As global protein synthesis was maintained at a constant rate for 8 hr of ex vivo culture in the absence of exogenously added insulin and serum (Figure 1A) and as insulin/serum might artificially stimulate protein synthesis, we omitted them for our short-term rapid protein labeling approach. Adult fly brains (8–10 per genotype) were harvested in Schneider’s medium and transferred to Schneider’s medium containing ³⁵S-methionine/cysteine (2 mCi/ml) to metabolically label newly-synthesized protein. Brains were incubated for 30 min at 25 °C with gentle orbital shaking, washed twice in 1 ml of PBS then flash frozen. Brains were homogenized in modified RIPA extraction buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 100 mM EGTA, 1% NP-40, 0.1% SDS, protease inhibitor cocktail) on ice using a pestle gun. After a 30 min incubation on ice, lysates were centrifuged at 14,000 × g for 15 min and the supernatant was retained. Protein was precipitated by the addition of methanol and heparin (lysate:heparin (100 mg/ml):methanol volume ratio of 150:1.5:600), centrifuged at 14,000 × g for 2 min, the supernatant was removed, and the pellet was air dried. The protein pellet was resuspended in 8 M urea/150 mM Tris, pH 8.5, and ³⁵S-methionine/cysteine incorporation was measured by liquid scintillation counting (counts per minute, CPM) and normalized to the number of brains.

Effect of PhAc-OPP on global protein synthesis

Adult fly brains (8–10 per genotype) from the standard laboratory control strain w¹¹¹⁸ were harvested in Schneider’s medium and transferred to Schneider’s medium containing ³⁵S-methionine/cysteine (2 mCi/ml) and PhAc-OPP at the indicated concentrations. Brains were incubated for 2 hr at 25 °C with gentle orbital shaking, washed twice in 1 ml of PBS then flash frozen. Thawed brains were homogenized and processed for protein precipitation and measurement of ³⁵S incorporation by scintillation counting as described above.

Rapid OPP/PhAc-OPP labeling of newly-synthesized CNS proteins

To enable rapid labeling of nascent CNS proteins, adult Drosophila brain explants maintained in Schneider’s Drosophila medium were incubated with OPP or PhAc-OPP within 30 min of collection (‘newly-isolated brains’). Brains (~15 for immunocytochemistry, 100 for enrichment, and immunoblotting) were harvested in Schneider’s medium and then immediately transferred to Schneider’s medium containing OPP (50 μM unless otherwise indicated) or PhAc-OPP (100 μM unless otherwise indicated) and MG-132 (60 μM) for 2 hr (unless otherwise indicated) at 25 °C with gentle orbital shaking. Brains were washed twice briefly in 1 ml PBS and then immediately processed for immunocytochemistry or enrichment and immunoblot detection as described below.

Immunocytochemical detection of OP-puromycylated protein

OP-puromycylated tissues were fixed for 20 min in 4% paraformaldehyde in PBS-T (PBS, pH 7.4 containing 0.3% Triton-X-100) at RT with gentle rocking, washed once in chilled PBS-T (5 min) and once in chilled PBS (5 min). Detection of OP-puromycylated protein was achieved by conjugation to a fluorophore-azide called AF488 picolyl azide (AF488-azide) via CuAAC click reaction. A click working reagent was prepared containing TBTA (200 μM), freshly prepared Cu(I)Br (0.5 mg/ml), AF488-azide (0.1 X concentration), and 1 X concentration OPP reaction buffer (the last two reagents derived from the Click-iT Plus OPP Alexa Fluor 488 Protein Synthesis Assay Kit (Invitrogen) and at concentrations relative to those recommended in the manufacturer’s instructions). The click working reagent was vortexed for 30 s then applied to brains and incubated for 30 min at 25 °C with gentle orbital shaking and protection from light. Tissues were washed briefly with 1 ml of Click-iT Reaction Rinse Buffer and either whole-mounted or additionally counterstained with Dylight Phalloidin-650 or immunostained for cell markers or DAPI stained prior to mounting. Tissues were imaged on a Zeiss LSM900 confocal microscope. For in-gel fluorescence assays, OPP/PhAc-OPP treated brains were lightly fixed (4% PFA/10 min), click-conjugated to AF488-azide as described above then lysed in de-crosslinking buffer (300 mM Tris-HCl/2% SDS/protease inhibitors) for 2 hr at 60 °C prior to SDS-PAGE, gel fixation (40% methanol/10% acetic acid), 30 min washing in ddH₂O, AF488-azide detection and subsequently total protein visualization using colloidal blue stain.

Immunoblot detection of enriched OP-puromycylated protein

The protocol is modified from Marter et al., 2019. Brains were thawed on ice and homogenized in 100 μL of homogenization buffer (0.5% SDS/PBS containing 2 X Complete EDTA-free Protease Inhibitor Cocktail). Samples were incubated on ice for 20 min with mixing every 5 min, at 95 °C for 5 min, then on ice for 5 min. Triton-X-100 was added to a final concentration of 0.2% and pre-equilibrated neutravidin agarose (25 μL/sample) was added to pre-clear lysates of endogenous biotinylated proteins via sample incubation on a nutator at 4 °C for 1 hr. Samples were centrifuged (3000 × g, 5 min, 4 °C) and to the supernatant, click chemistry reagents were added as follows: TBTA (final concentration 200 μM), desthiobiotin azide (20 μM), freshly prepared Cu(I)Br (0.5 mg/ml). On each addition, samples were vortexed for 10 s. Samples were incubated overnight on a nutator at 4 °C, centrifuged at 3000 × g for 5 min/4 °C then the supernatant was diluted in PBS with 2 X protease inhibitor cocktail to a final volume of 300 μl and desalted (Zeba spin desalting columns). Total protein concentration in lysates was determined by BCA assay to standardize input for neutravidin agarose enrichments. Neutravidin agarose was equilibrated in 1% NP-40/PBS for three washes and 1% NP-40 was added to desalted lysates for 20 min on ice. After removing a portion of the lysate for input analysis, samples were added to equilibrated neutravidin agarose (50 μL/sample) and incubated overnight at 4 °C on a nutator. Samples were centrifuged (3000 × g, 5 min, 4 °C) and washed in 1% NP-40/2 X protease inhibitor cocktail/PBS five times than in PBS for three additional washes, with 2 min of end-over-end mixing at each wash step. Desthiobiotin-conjugated protein was eluted from neutravidin agarose by incubating in 8 mM biotin for 1 hr in a thermomixer at 25 °C/1200 rpm shaking. Laemmli buffer was then added to eluate and input for downstream analysis by immunoblotting.

Rapid PhAc-OPP labeling of larval tissues for immunocytochemical detection

Wandering L3 larvae were washed briefly in PBS and then inverted to expose bodily tissues to the surrounding solution for labeling. Inverted larval preps were immediately transferred to Schneider’s medium, then incubated with 100 μM PhAc-OPP and 60 μM MG-132 followed by PFA fixation and click conjugation to AF488-azide under the same conditions used for adult fly brains. Tissues targeted for imaging (fat body, trachea, muscle, and salivary glands) were separated, counterstained with Dylight Phalloidin-650, and mounted for imaging on a Zeiss LSM 900 confocal microscope.

Adult survival

Adult females (0–3 days of age, 100–150 flies per genotype, selecting against newly-eclosed flies) were collected under brief anesthesia and transferred to fresh food vials at 25 flies per vial. Flies were then transferred to fresh food vials every 3–4 days throughout the experiment and dead or censored (escaped or stuck in food) flies were counted during each transfer to fresh food.

Negative geotaxis behavior

Cohorts of 75–100 female flies (0–3 days old, selecting against flies with visible signs of recent eclosion) were collected under brief anesthesia and transferred to fresh food vials to recover (25 flies/vial). Flies were aged for 6 weeks with transfer to fresh food twice per week. On the day of testing, flies were transferred to empty vials, allowed 1 min to rest and then tapped to the bottom of the vial three times within a 1 s interval to initiate climbing. The position of each fly was captured in a digital Figure 4 second after climbing initiation. Automated image analysis was performed using the particle analysis tool on Scion Image to derive x–y coordinates for each fly thus providing the height climbed, as previously described (Gargano et al., 2005). The performance of flies in a single vial was calculated from the average height climbed by all flies in that vial to generate a single datum (N=1). Performance of each line was then derived from the average scores of 5–6 vials tested for the line (N=5–6).

Food intake

Blue dye (erioglaucine disodium salt) was added at 1.5% w/v to the food during preparation to measure food consumption as previously described (Chittoor-Vinod et al., 2020). Briefly, flies were housed for 4 hr on dye-containing food with or without the presence of 4 mM PhAc-OPP, flash frozen in liquid nitrogen, washed in chilled water, lysed in chilled water, centrifuged (15 min/13,000 rpm/4 °C) and supernatants were assessed for OD 620 nm (SpectraMax i3x). OD readings were normalized to the number of flies in the lysate.

Western blotting

Samples were electrophoresed on 4–20% Tris-Glycine gradient gels and transferred to nitrocellulose membrane for immunoblotting using the following antibodies:

From the Developmental Studies Hybridoma Bank: Brp (nc82) 1:50; Synapsin-1 (3C11) 1:500; Syntaxin (8C3) 1:500; Drpr (1:1 mix of 5D14:8A1) 1:400; Repo (8D12) 1:200. Other antibodies used were biotin (Bethyl Laboratories) 1:1000; FLAG (M2) (Sigma) 1:500; TH (Immunostar) 1:1000; Actin-HRP (Sigma) 1:1000; Ubiquitin (P4D1) (Cell Signaling Technology) 1:1000; GAPDH (GA1R) (ThermoFisher Scientific) 1:10,000.

Statistical analysis

Quantified data are mean ± SEM and individual data points are plotted for data with n<10. Sample sizes for time-course experiments were determined based on evidence from pilot experiments. Statistical analysis details for each individual experiment are described in figure legends, including the number of flies or the number of groups of flies used (n), statistical tests (unpaired two-tailed Student’s t-test, ANOVA or two-way ANOVA), and Bonferroni post hoc analysis with associated p values. All statistical analyses were performed using GraphPad Prism except Log-rank (Mantel-Cox) tests for lifespan comparisons performed in SPSS.

Data availability

All data generated or analyzed during this study are included in the manuscript’s main Figures or Figure supplements. Source data are provided for Western blots and gels.

Materials availability

Newly created Drosophila line (UAS-PGA) has been deposited at the Bloomington Drosophila Stock Center (stock ID pending) and will be shared upon request.

Additional information

Competing interests

No competing interests declared

Author contributions

Conceptualization, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing – review and editing

Conceptualization, Formal analysis, Investigation, Methodology, Writing – review and editing

Conceptualization, Formal analysis, Validation, Investigation, Methodology, Writing – review and editing

Formal analysis, Investigation, Writing – review and editing

Investigation

Conceptualization, Resources, Methodology, Writing – review and editing

Conceptualization, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing – review and editing

Additional files

MDAR checklist

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files.

Acknowledgements

We thank Richard Goodman and Chris Doe for initial discussions on the project, Chris Doe and Sen-Lin Lai for providing PGA cDNA, the OHSU Advanced Light Microscopy Core for microscope use, and the OHSU Medicinal chemistry core for PhAc-OPP synthesis. The following antibodies were obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and maintained at The University of Iowa: Brp nc82 and Synapsin 3C11 (developed by E Buchner), Syntaxin 8C3 (S Benzer and N Colley), Draper 8A1 and 5D14 (M Logan) and Elav 9F8A9 (G Rubin). This work was funded by OHSU Neurology Foundation Funds (IM).

References

Alvarez-Castelao

Schanzenbächer

Hanus

Glock

Tom Dieck

Dörrbaum

Bartnik

Nassim-Assir

Ciirdaeva

Mueller

Dieterich

Tirrell

Langer

Schuman

2017

Cell-Type-Specific metabolic labeling of nascent proteomes in vivo

Nature Biotechnology3511961201

10.1038/nbt.4016

29106408

Ayaz

Leyssen

Koch

Yan

Srahna

Sheeba

Fogle

Holmes

Hassan

2008

Axonal injury and regeneration in the adult brain of Drosophila

The Journal of Neuroscience2860106021

10.1523/JNEUROSCI.0101-08.2008

18524906

Bagert

Xie

Sweredoski

Hess

Schuman

Tirrell

2014

Quantitative, time-resolved proteomic analysis by combining bioorthogonal noncanonical amino acid tagging and pulsed stable isotope labeling by amino acids in cell culture

Molecular & Cellular Proteomics1313521358

10.1074/mcp.M113.031914

24563536

Barrett

Liu

Jin

Goodman

Cohen

2016

Cell-specific profiling of nascent proteomes using orthogonal enzyme-mediated puromycin incorporation

ACS Chemical Biology1115321536

10.1021/acschembio.5b01076

27074634

Brar

Weissman

2015

Ribosome profiling reveals the what, when, where and how of protein synthesis

Nature Reviews. Molecular Cell Biology16651664

10.1038/nrm4069

26465719

Brown

HLD

Cherbas

Truman

2006

Use of time-lapse imaging and dominant negative receptors to dissect the steroid receptor control of neuronal remodeling in Drosophila

Development133275285

10.1242/dev.02191

16354717

Calve

Witten

Ocken

Kinzer-Ursem

2016

Incorporation of non-canonical amino acids into the developing murine proteome

Scientific Reports6

32377

10.1038/srep32377

27572480

Chittoor-Vinod

Villalobos-Cantor

Roshak

Shea

Abalde-Atristain

Martin

2020

Dietary amino acids impact LRRK2-induced neurodegeneration in Parkinson’s disease models

The Journal of Neuroscience4062346249

10.1523/JNEUROSCI.2809-19.2020

32605938

Doyle

Dougherty

Heiman

Schmidt

Stevens

Bupp

Shrestha

Shah

Doughty

Gong

Greengard

Heintz

2008

Application of a translational profiling approach for the comparative analysis of CNS cell types

Cell135749762

10.1016/j.cell.2008.10.029

19013282

Erdmann

Marter

Kobler

Niehues

Abele

Müller

Bussmann

Storkebaum

Ziv

Thomas

Dieterich

2015

Cell-Selective labelling of proteomes in Drosophila melanogaster

Nature Communications6

7521

10.1038/ncomms8521

Essers

Tain

Nespital

Goncalves

Froehlich

Partridge

2016

Reduced insulin/insulin-like growth factor signaling decreases translation in Drosophila and mice

Scientific Reports6

30290

10.1038/srep30290

27452396

Fleming

Quattrocki

Latter

Miquel

Marcuson

Zuckerkandl

Bensch

1986

Age-dependent changes in proteins of Drosophila melanogaster

Science23111571159

10.1126/science.3080809

3080809

Forester

Zhao

Phillips

Urisman

Chalkley

Oses-Prieto

Zhang

Ruggero

Burlingame

2018

Revealing nascent proteomics in signaling pathways and cell differentiation

PNAS11523532358

10.1073/pnas.1707514115

29467287

Gargano

Martin

Bhandari

Grotewiel

2005

Rapid iterative negative geotaxis (ring): a new method for assessing age-related locomotor decline in Drosophila

Experimental Gerontology40386395

10.1016/j.exger.2005.02.005

15919590

Gibbs

Truman

1998

Nitric oxide and cyclic GMP regulate retinal patterning in the optic lobe of Drosophila

Neuron208393

10.1016/s0896-6273(00)80436-5

9459444

Gkogkas

Khoutorsky

Ran

Rampakakis

Nevarko

Weatherill

Vasuta

Yee

Truitt

Dallaire

Major

Lasko

Ruggero

Nader

Lacaille

J-C

Sonenberg

2013

Autism-related deficits via dysregulated eIF4E-dependent translational control

Nature493371377

10.1038/nature11628

23172145

Greenblatt

Spradling

2018

Fragile x mental retardation 1 gene enhances the translation of large autism-related proteins

Science361709712

10.1126/science.aas9963

30115809

Griesser

Wyatt

Ten Have

Stierstorfer

Lenter

Lamond

2020

Quantitative profiling of the human substantia nigra proteome from laser-capture microdissected FFPE tissue

Molecular & Cellular Proteomics19839851

10.1074/mcp.RA119.001889

32132230

O’Dowd

2006

Cholinergic synaptic transmission in adult Drosophila kenyon cells in situ

The Journal of Neuroscience26265272

10.1523/JNEUROSCI.4109-05.2006

16399696

Hidalgo San Jose

Signer

RAJ

2019

Cell-Type-Specific quantification of protein synthesis in vivo

Nature Protocols14441460

10.1038/s41596-018-0100-z

Jan

2010

Branching out: mechanisms of dendritic arborization

Nature Reviews. Neuroscience11316328

10.1038/nrn2836

20404840

Kim

Yin

Jhaldiyal

Khan

Martin

Xie

Perez-Rosello

Kumar

Abalde-Atristain

Chen

Eacker

Surmeier

Ingolia

Dawson

2020

Defects in mrna translation in lrrk2-mutant hipsc-derived dopaminergic neurons lead to dysregulated calcium homeostasis

Cell Stem Cell27633645

10.1016/j.stem.2020.08.002

32846140

Lee

C-Y

Andersen

Cabernard

Manning

Tran

Lanskey

Bashirullah

Doe

2006

Drosophila Aurora-A kinase inhibits neuroblast self-renewal by regulating apkc/numb cortical polarity and spindle orientation

Genes & Development2034643474

10.1101/gad.1489406

17182871

Han

Udeshi

Svinkina

Mani

Guajardo

Xie

Luginbuhl

McLaughlin

Xie

Kaewsapsak

Quake

Carr

Ting

Luo

2020

Cell-Surface proteomic profiling in the fly brain uncovers wiring regulators

Cell180373386

10.1016/j.cell.2019.12.029

Liu

Stoleru

Salic

2012

Imaging protein synthesis in cells and tissues with an alkyne analog of puromycin

PNAS109413418

10.1073/pnas.1111561108

22160674

Bergert

Walther

Suter

2014

Double-sieving-defective aminoacyl-trna synthetase causes protein mistranslation and affects cellular physiology and development

Nature Communications5

5650

10.1038/ncomms6650

25427601

Mangleburg

Yalamanchili

Guo

Hsieh

Duong

Dammer

De Jager

Seyfried

Liu

Shulman

2020

Integrated analysis of the aging brain transcriptome and proteome in tauopathy

Molecular Neurodegeneration15

10.1186/s13024-020-00405-4

32993812

Marter

Kobler

Erdmann

Soleimanpour

Landgraf

Müller

Abele

Thomas

Dieterich

2019

Click chemistry (CuAAC) and detection of tagged de novo synthesized proteins in Drosophila

BIO-PROTOCOL9

e3142

10.21769/BioProtoc.3142

Martin

Grotewiel

2006

Distinct genetic influences on locomotor senescence in Drosophila revealed by a series of metrical analyses

Experimental Gerontology41877881

10.1016/j.exger.2006.06.052

16891076

Martin

Abalde-Atristain

Kim

Dawson

2014a

Abberant protein synthesis in g2019s lrrk2 Drosophila parkinson disease-related phenotypes

Fly8165169

10.4161/19336934.2014.983382

25483009

Martin

Kim

Lee

Kang

Jia

Stankowski

Kim

Zhong

Kumar

Andrabi

Xiong

Dickson

Wszolek

Pandey

Dawson

2014b

Ribosomal protein s15 phosphorylation mediates lrrk2 neurodegeneration in parkinson’s disease

Cell157472485

10.1016/j.cell.2014.01.064

24725412

Martin

2016

Decoding parkinson’s disease pathogenesis: the role of deregulated mRNA translation

Journal of Parkinson’s Disease61727

10.3233/JPD-150738

26889638

Mizielinska

Grönke

Niccoli

Ridler

Clayton

Devoy

Moens

Norona

Woollacott

IOC

Pietrzyk

Cleverley

Nicoll

Pickering-Brown

Dols

Cabecinha

Hendrich

Fratta

Fisher

EMC

Partridge

Isaacs

2014

C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins

Science34511921194

10.1126/science.1256800

25103406

Nathans

1964

Puromycin inhibition of protein synthesis: incorporation of puromycin into peptide chains

PNAS51585592

10.1073/pnas.51.4.585

14166766

Noyes

Phan

Davis

2021

Memory suppressor genes: modulating acquisition, consolidation, and forgetting

Neuron10932113227

10.1016/j.neuron.2021.08.001

34450024

Owald

Fouquet

Schmidt

Wichmann

Mertel

Depner

Christiansen

Zube

Quentin

Körner

Urlaub

Mechtler

Sigrist

2010

A syd-1 homologue regulates pre- and postsynaptic maturation in Drosophila

The Journal of Cell Biology188565579

10.1083/jcb.200908055

20176924

Piper

MDW

Partridge

2018

Drosophila as a model for ageing

Biochimica et Biophysica Acta. Molecular Basis of Disease186427072717

10.1016/j.bbadis.2017.09.016

28964875

Robichaud

Sonenberg

2017

Translational control and the cancer cell response to stress

Current Opinion in Cell Biology45102109

10.1016/j.ceb.2017.05.007

28582681

Schwanhäusser

Busse

Dittmar

Schuchhardt

Wolf

Chen

Selbach

2011

Global quantification of mammalian gene expression control

Nature473337342

10.1038/nature10098

21593866

Şentürk

Bellen

2018

Genetic strategies to tackle neurological diseases in fruit flies

Current Opinion in Neurobiology502432

10.1016/j.conb.2017.10.017

29128849

Sossin

Costa-Mattioli

2019

Translational control in the brain in health and disease

Cold Spring Harbor Perspectives in Biology11

a032912

10.1101/cshperspect.a032912

30082469

Steward

Eilers

Tripet

Fuchs

Dorle

Rawle

Soriano

Balasubramanian

Copié

Bothner

Hatzenpichler

2020

Metabolic implications of using bioorthogonal non-canonical amino acid tagging (BONCAT) for tracking protein synthesis

Frontiers in Microbiology11

197

10.3389/fmicb.2020.00197

32117186

Tanrikulu

Schmitt

Mechulam

Goddard

Tirrell

2009

Discovery of Escherichia coli methionyl-trna synthetase mutants for efficient labeling of proteins with azidonorleucine in vivo

PNAS1061528515290

10.1073/pnas.0905735106

19706454

Wang

Wong

Flores

Vosshall

Axel

2003

Two-Photon calcium imaging reveals an odor-evoked map of activity in the fly brain

Cell112271282

10.1016/s0092-8674(03)00004-7

12553914

Wang

Shui

Lin

Zhang

Wen

Deng

Guo

Xue

Zhang

2020

Integrated omics in Drosophila uncover a circadian kinome

Nature Communications11

2710

10.1038/s41467-020-16514-z

32483184

Wiebe

Nagpal

Sonenberg

2020

Dysregulated translational control in brain disorders: from genes to behavior

Current Opinion in Genetics & Development653441

10.1016/j.gde.2020.05.005

32535350

Yang

Cao

Zhao

Fang

Liu

Zhang

2019

Multidimensional proteomics identifies declines in protein homeostasis and mitochondria as early signals for normal aging and age-associated disease in Drosophila

Molecular & Cellular Proteomics1820782088

10.1074/mcp.RA119.001621

31434710

10.7554/eLife.83545.sa0

Editor's evaluation

Bellen

Hugo J

Reviewing Editor

https://ror.org/02pttbw34

Baylor College of Medicine

United States

The authors developed a versatile labeling strategy to allow visualization and identification of newly synthesized proteins in a cell population of interest. The approach enables cell-specific nascent proteome labeling from brain tissues to examine the role of translational control in different physiological and pathological states.

10.7554/eLife.83545.sa1

Decision letter

Bellen

Hugo J

Reviewing Editor

https://ror.org/02pttbw34

Baylor College of Medicine

United States

Our editorial process produces two outputs: (i) public reviews designed to be posted alongside the preprint for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.

Decision letter after peer review:

Thank you for submitting your article "Rapid Cell Type-Specific Nascent Proteome Labeling in Drosophila" for consideration by eLife. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and K VijayRaghavan as the Senior Editor. The reviewers have opted to remain anonymous.

The authors describe a potentially useful method to quantitatively identify and visualize the nascent proteome of individual cell populations. The characterization of the approach is incomplete and preliminary, and the method needs to be better validated.

The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.

Essential revisions:

1. Test if PhAc-OPP penetrates into various non-brain dissected tissues, such as muscle, fat body, and trachea. Etc. This could be done in larvae by dissecting and inverting larvae, and exposing various tissues to the PhAc-OPP in solution.

2. Test if ingested PhAc-OPP penetrates into the adult brain expressing elav>PGA.

What are the pros/cons of this method versus currently available methods based on ribosome profiling? The sensitivity of this method would be good to comment on in comparison with existing methods. Also, when would this be the method of choice over other methods?

3. How available are the reagents needed for POPPi, and are they easy to obtain by any research lab?

4. The reagent AF488-azide is referred to differently in different places in the manuscript and was not well introduced or described.

5. Because OPP incorporation is sequence-independent, it should be able to label and terminate a peptide chain at any amino acid residue. Therefore I would expect the western blot to show a wider band or a smear after OPP or POPPi labeling. However, all the blots shown in the paper show similarly sharp bands as in the corresponding controls. Can the authors provide an explanation? Are the shorter (incomplete) peptides being degraded very quickly?

6. Many of the issues raised by reviewer 3 are important and should be addressed.

In essence, the characterization of the method needs to be extended and validated.

Reviewer #1 (Recommendations for the authors):

To address my main criticism in the public review, I suggest the following experiments.

2. Test if ingested PhAc-OPP penetrates into the adult brain expressing elav>PGA.

Reviewer #2 (Recommendations for the authors):

I would like the authors to address the following questions:

How available are the reagents needed for POPPi, and are they easy to obtain by any research lab?

The reagent AF488-azide is referred to differently in different places in the manuscript and was not well introduced or described.

Because OPP incorporation is sequence-independent, it should be able to label and terminate a peptide chain at any amino acid residue. Therefore I would expect the western blot to show a wider band or a smear after OPP or POPPi labeling. However, all the blots shown in the paper show similarly sharp bands as in the corresponding controls. Can the authors provide an explanation? Are the shorter (incomplete) peptides being degraded very quickly?

Reviewer #3 (Recommendations for the authors):

1. It is not clear what percentage of the newly synthesized polypeptides incorporate puromycin which would allow visualization or immunopurification of the protein through the use of azide conjugates. Since the inclusion of puromycin in the nascent peptide prevents further elongation of the nascent peptide, reaching the levels of puromycin to saturate the cells would likely be detrimental. On the other hand, when lower amounts of puromycin are used, it is likely that the lower expressed genes/polypeptides will not be labelled. In any case, the authors should estimate the ratio of the newly synthesized targeted by puromycin. This can be done by using PhAc-OPP in elav-Gal4 UAS-PGA brains in combination with azide-biotin and S35 methionine. This would allow immunopurification with an antibody specific for a protein (such as bruchpilot), measuring the level of S35, and a second immunopurification with streptavidin and measuring again with S35. This can allow the estimation of the percentage of newly synthesized proteins that are targeted by PhAc-OPP.

2. It is not clear how there can be clear full-size bands in the Western blots in figure 3. The addition of PhAc-OPP should truncate the protein at random sites that correspond to where the OPP is added to the nascent peptide. This should result in smears in principle unless there is a tendency of OPP to get incorporated towards the end of the protein. An explanation should be included in the discussion to help the reader understand the data better. This also undermines the argument that the fact that there are bands of different sizes suggests that the proteome is uniformly targeted. Since puromycin addition truncates the gene products at random positions, the band sizes should not be informative and indicative of unbiased labelling of the proteome.

3. Although the imaging using OPP and Alexa488-azide looks rather uniform labeling in figure 1C when PhAc-OPP is used in combination with elav-Gal4 or repo-Gal4 UAS-PGA, the Alexa488-azide signal is much more salt and pepper distributed in figure 2A and D (especially in the magnified insets). This is especially prominent in glia where very few of the mCherry expressing cells are labelled by Alexa488-azide in Figure 2D. This suggests that the proteome of some cells will be much higher represented in the samples when azide-biotin is used to immunopurified proteins expressed by a cell type, severely limiting the use of the technique.

4. The fact that OPP-mediated labeling is quite uniform suggests that the translation levels do not change very much between cells and the reason for the non-uniform signal in figure2 may result from the non-uniform expression of UAS-PGA. The authors should stain the elav-Gal4 or repo-Gal4 UAS-PGA with an anti-Flag antibody to check for non-uniform expression of PGA.

5. In figure 1 figure supplement 2B the authors should test incubation times that are between 0-2 hours better since at 2 hours the system already seems to be saturated.

In summary, the technique needs to be better characterized to be more usable by the fly community. In addition, the demonstration experiments to show that there is an age-dependent decrease in translation rates are not the most informative demonstration of the use of the technique. Hence, this manuscript needs major revision and a better demonstration of the use of the technique to warrant publication in eLife.

[Editors’ note: further revisions were suggested prior to acceptance, as described below.]

Thank you for resubmitting your work entitled "Rapid Cell Type-Specific Nascent Proteome Labeling in Drosophila" for further consideration by eLife. Your revised article has been evaluated by K VijayRaghavan (Senior Editor) and a Reviewing Editor.

The manuscript has been improved but there are some remaining issues that need to be addressed, as outlined by the reviewer. It is really important to address these concerns in detail. Please can you do this at the earliest and submit a revised manuscript?

Reviewer #1 (Recommendations for the authors):

The authors satisfied the major concerns in my original review. However, I have an additional major concern.

The data presented do not convince me that POPPi is a robust and useful method for capturing and identifying newly-synthesized proteins in a cell type-specific manner (e.g. w/ biotin-azide). In the response to my concern of my original review, the authors suggest that background bands seen in negative control lanes of western blots (e.g. now Figure 4A) are due to non-specific AF488-azide incorporation into all proteins (newly synthesized + old). This is unexpected to me, as I had assumed the click chemistry was specific to OPP-labeled proteins. Regardless, assuming that non-OPP-labeled proteins are labeled by AF488-azide, I interpret the western blots in Figure 4A and Figure 4C as showing weak 'signal above background'. This is especially concerning because Figure 4A,C were performed by labeling a large portion of the cells within the collected tissue (pan-neuron and pan-glia). So, labeling in smaller subsets of cell types (e.g. dopaminergic neurons) would be expected to result in even lower 'signal above background'. I outline below additional thoughts and suggestions that could help address my concerns.

Recommendations for the authors:

1. To more accurately assess the signal-to-background of cell type-specific labeled proteins, the authors should provide a proper negative control in Figure 4A and 4C. The "vehicle-only" negative control may underestimate the background levels of AF488-azide incorporation. I would argue that the most appropriate negative control is to incubate wild-type brains (e.g. elav>GFP) with PhAc-OPP. Hypothetically, PhAc-OPP could be uncaged by endogenous fly enzymes, which would result in higher background levels than the vehicle-only control. As far as I can tell, the possibility of uncaging PhAc-OPP without PGA is not discussed and remains untested in this manuscript. Furthermore, line 203 "PGA-dependent unblocking of PhAc-OPP…" is thus not supported by their data using the "vehicle-only" negative control in Figure 4. I suggest that the authors repeat the data in Figure 4A and 4C using the appropriate negative control I mentioned.

2. The authors should provide western blots similar to Figures 4A,C, but using the biotin-azide labeling reagent. Since biotin-azide enables researchers to capture and detect OPP-labeled proteins using streptavidin-bead pulldown, it is critical that researchers understand the global signal-to-background when using this reagent. I suggest that the authors repeat Figure 4A,C using biotin-azide to label and streptavidin-fluorophore to detect. Furthermore, since Drosophila contains naturally biotinylated proteins, these new western blots would provide the fairest representation of signal-to-background. For example, naturally biotinylated proteins will bind to the streptavidin beads and thus be background on western blots and in Mass spectrometry (MS) data.

3. I would like to see MS data to support the data presented in Figure 4 B,D. These figures show that POPPi can enrich cell type-specific labeled proteins. However, the background bands for Synapsin, Syntaxin, and Draper are concerning and suggest the sensitivity of this method is low. To convince me that there is global signal over background, I would like to see MS analysis of samples in Figure 4B,D. For example, MS of streptavidin-pulldown from the following brain genotypes (1) elav>PGA + PhAc-OPP, (2) repo>PGA + PhAc-OPP, (3) elav>GFP + PhAc-OPP. Using quantitative approaches such as TMT labeling or SAINT analysis, I would expect to see enrichment of Draper to glia and Syntaxin to neurons, for example.

Reviewer #2 (Recommendations for the authors):

I'm generally satisfied with the responses and changes to the manuscript. My only remaining request is that the authors include a line for PhAc-OPP in the Key Resources Table. Clearly, this is a key reagent, and the authors should be transparent that it is something that needs to be synthesized, which will likely limit how widespread the method is used by the community.

10.7554/eLife.83545.sa2

Author response

Essential revisions:

We thank the reviewer for suggesting this approach to assessing PhAc-OPP penetration into other tissues besides brain. We inverted L3 larvae expressing PGA via the Actin5C-Gal4 driver, and then immediately incubated inverted larvae in 100 µM PhAc-OPP for 2h under the same conditions as previously used for labeling brain tissue. Our prior results indicate robust PGA expression in larvae from this genotype (Figure 1 —figure supplement 1). Upon dissecting and imaging individual tissues (fat body, trachea, muscle and salivary gland), we observed readily detectable protein synthesis labeling. This indicates that PhAc-OPP is able to penetrate a variety of tissues besides the brain to label newly-synthesized protein. These results are presented in the revised manuscript (Figure 3), Results (line 190), Discussion (line 367) and Methods (line 542).

2. Test if ingested PhAc-OPP penetrates into the adult brain expressing elav>PGA.

To assess the feasibility of protein synthesis labeling via dietary PhAc-OPP intake, we exposed pan-neuronal PGA-expressing flies (elav-Gal4>UAS-PGA) to various concentrations of PhAc-OPP in sugar/yeast extract food for 48h then determined whether OPP-labeled nascent protein is detectable following AF488-azide conjugation. We observe concentration-dependent labeling with PhAc-OPP and AF488azide signal becomes significantly higher than background at concentrations ≥1 mM (Figure 7A and 7B). Importantly, flies appear to consume 4 mM PhAc-OPP-containing food in similar quantities to that of control food (Figure 7C), suggesting that food consumption is not significantly impaired by the presence of PhAc-OPP, even at the highest dose tested. These results suggest that PhAc-OPP administered dietarily can penetrate the brain at levels sufficient to obtain detectable albeit subtle nascent protein labeling. These results are described in the Results (line 265), Discussion (line 370) and Methods (line 438).

We addressed questions related to the pros/cons, sensitivity etc. of our method in new text added to the manuscript Discussion as follows:

“Current proteomic approaches for measuring protein synthesis harbor strengths and weaknesses compared to transcriptomic approaches. Ribosomal profiling and other ribosome capture methods such as TRAP measure ribosomal density on a given transcript which provides a proxy for the rate of protein synthesis but not an actual measure of protein product. Ribosomal profiling has provided important insights into mechanisms of translational control, yet, there are some weaknesses to the method (45). Perhaps most importantly, inferring protein synthesis rates from a single snapshot of average ribosomal occupancy on a given mRNA is based on assumptions that all ribosomes complete translation, and are not subject to regulated translational pausing or abortion at the time of capture or at any time prior to finishing translation. Additionally, the method itself may miss ribosomal footprints if nuclease digestion is incomplete, and give rise to false readouts of translation from contaminating non-coding RNA fragments. In contrast, assessing translation at the level of synthesized protein, e.g. through quantitative proteomics, should avoid errors associated with inferring protein synthesis rates from ribosomal occupancy, with the caveat that sensitivity limits relative to transcriptomic approaches may make transcriptomics the method of choice when starting material is low. We believe a potential major advantage of POPPi over existing methods for measuring cell type-specific protein synthesis is its efficiency, particularly for visualizing protein synthesis – PhAc-OPP labeling coupled to AF488-azide conjugation can be completed within a few hours (see Methods). Future work will seek to understand the full capabilities and limitations of POPPi, e.g. for profiling rare cell populations in the brain.”

3. How available are the reagents needed for POPPi, and are they easy to obtain by any research lab?

PhAc-OPP is not currently commercially available, yet its chemical synthesis has been previously described in detail (Reference 12) which labs can use to have the compound synthesized, e.g. through a university chemistry core or a company. All other compounds used for the methods described are commercially available, including AF488-azide for visualizing protein synthesis and desthiobiotin-azide for enriching labeled protein. All reagent details are provided in the key resources table. PGA transgenic flies will be made available upon request, as indicated in the manuscript.

4. The reagent AF488-azide is referred to differently in different places in the manuscript and was not well introduced or described.

We now consistently refer to this reagent in its short form (AF488-azide) throughout the manuscript except when introducing the reagent in the Methods, where we added the statement “Detection of OP-puromycylated protein was achieved by conjugation to a fluorophore-azide called AF488 picolyl azide (AF488-azide) via CuAAC click reaction”. We regret the prior lack of clarity.

It is likely that truncated proteins would be targeted for eventual degradation and depleted from the protein pool as the reviewer indicates. However, another simple explanation is that commercially available antibodies used for Brp, Synapsin and Draper are all reported to recognize epitopes at the C-terminal end of these proteins, which would be absent in most truncated protein and therefore not detectable on Western blot. The epitope for Syntaxin has not been mapped. Hence, the depletion of truncated proteins combined with an inability to detect them using the available antibodies used in this study likely explain their absence of western blots. We added this interpretation to the Discussion (line 337).

6. Many of the issues raised by reviewer 3 are important and should be addressed.

Please see our point-by-point response to reviewer 3 comments below.

In essence, the characterization of the method needs to be extended and validated.

Our new findings presented in the revised manuscript support the capability of our method to (i) label newly-synthesized protein in Drosophila tissues besides the brain and (ii) label newly-synthesized protein in the brain when the labeling compound PhAc-OPP is administered to flies dietarily. We believe these revisions extend characterization of the method substantially.

Reviewer #1 (Recommendations for the authors):

To address my main criticism in the public review, I suggest the following experiments.

2. Test if ingested PhAc-OPP penetrates into the adult brain expressing elav>PGA.

Reviewer #2 (Recommendations for the authors):

I would like the authors to address the following questions:

To address these questions, the following text has been added to the Discussion (line 386):

“Current proteomic approaches for measuring protein synthesis harbor strengths and weaknesses compared to transcriptomic approaches. Ribosomal profiling and other ribosome capture methods such as TRAP measure ribosomal density on a given transcript which provides a proxy for the rate of protein synthesis but not an actual measure of protein product. Ribosomal profiling has provided important insights into mechanisms of translational control, yet, there are some weaknesses to the method (45). Perhaps most importantly, inferring protein synthesis rates from a single snapshot of average ribosomal occupancy on a given mRNA is based on assumptions that all ribosomes complete translation, and are not subject to regulated translational pausing or abortion at the time of capture or at any time prior to finishing translation. Additionally, the method itself may miss ribosomal footprints if nuclease digestion is incomplete, and give rise to false readouts of translation from contaminating non-coding RNA fragments. In contrast, assessing translation at the level of synthesized protein, e.g. through quantitative proteomics, should avoid errors associated with inferring protein synthesis rates from ribosomal occupancy, with the caveat that sensitivity limits relative to transcriptomic approaches may make transcriptomics the method of choice when starting material is low. We believe a potential major advantage of POPPi over existing methods for measuring cell type-specific protein synthesis is its efficiency, particularly for visualizing protein synthesis – PhAc-OPP labeling coupled to AF488azide conjugation can be completed within a few hours (see Methods). Future work will seek to understand the full capabilities and limitations of POPPi, e.g. for profiling rare cell populations in the brain.”

How available are the reagents needed for POPPi, and are they easy to obtain by any research lab?

The reagent AF488-azide is referred to differently in different places in the manuscript and was not well introduced or described.

It is likely that truncated proteins would be targeted for eventual degradation and depleted from the protein pool as the reviewer indicates. However, another simple explanation is that commercially available antibodies used for Brp, Synapsin and Draper are all reported to recognize epitopes at the C-terminal end of these proteins, which would be absent in most truncated protein and therefore not detectable on Western blot. The epitope for Syntaxin has not been mapped. Hence, the combined depletion of truncated proteins in addition to an inability to detect them using the available antibodies used in this study likely explain their absence of western blots. We added this interpretation to the Discussion (line 337).

Reviewer #3 (Recommendations for the authors):

This is conceptually an interesting approach, although we believe there are major practical constraints that render this approach and the suggested experiment unlikely to provide quantitatively meaningful results. First, IP would likely not work well since the available antibodies to our assessed cell type-specific proteins bind to Cterminal epitopes, thus missing any truncated protein fragments and therefore likely a substantial portion of labeled newly-synthesized protein. Second, streptavidin enrichment is expected to enrich all labeled cellular protein, not just the protein-ofinterest, and hence, the ³⁵S signal for any single protein-of-interest would have to be distinguished from all the other proteins in the eluate. This is potentially feasible by combining autoradiography with western blot, yet due to the antibody issue mentioned above, we would again likely miss any truncated labeled protein present.

Please see response to the last comment of Reviewer 2.

To clarify, glial cell bodies populate the brain cell cortex at much lower numbers than neurons, but cortex glia form an extensive network around their surrounding neurons with each glial cell encapsulating many neurons. This gives the membrane-tethered mCherry signal a honeycomb-like appearance where the majority of mCherry signal is not from glial cell bodies but from glial membrane extensions that spread across the neuronal network (Figure 2D). While these membrane extensions do not appear AF488-azide labeled, most of the solidly-filled glial cell bodies do, consistent with predominant cell body protein synthesis labeling we observe with neurons and with unblocked OPP. However, we acknowledge that there appears to be more overall cellto-cell variability in generally cellular AF488-azide signal when brains are incubated in PhAc-OPP compared to unblocked OPP, although there is also some variability in labeling with unblocked OPP (Figure 1C and Figure 1 —figure supplement 2), which is not dependent on PGA-induced unblocking. This suggests that variability in protein synthesis labeling may be partly due to cell-to-cell differences in global translation, and partly due to differences in PGA expression (see below).

We performed FLAG immunostaining of elav-Gal4>UAS-PGA adult brains and observed non-uniform FLAG levels between cells suggesting a degree of cell-to-cell variability in PGA expression. The data are presented in Figure 2 —figure supplement 1 and described in the Results (line 168).

5. In figure 1 figure supplement 2B the authors should test incubation times that are between 0-2 hours better since at 2 hours the system already seems to be saturated.

Indeed, at 2h of labeling with unblocked OPP labeling, AF488-azide signal is close to maximal and based on this OPP result, we focused on shorter time points (e.g. 1 hour) with PhAc-OPP (Figure 2B). We did not pursue additional time points with unblocked OPP, since PhAc-OPP is the main focus of our study.

[Editors’ note: further revisions were suggested prior to acceptance, as described below.]

Reviewer #1 (Recommendations for the authors):

The authors satisfied the major concerns in my original review. However, I have an additional major concern.

We are pleased that our resubmitted manuscript satisfied major concerns in the Reviewer’s original review.

Regarding the additional point raised, it is important to note that the presence of background AF488-azide binding to protein is mainly restricted to brain lysates as we do not see significant background in control groups assessed in confocal imaged wholemount brains (Figure 2A, C and D) or other fly tissues (Figure 3) incubated in PhAcOPP then in AF488-azide. We would also like to point out that these gels show total brain lysates, i.e. there is no enrichment for labeled protein. As indicated in our original response, our primary intended application for the AF488-azide reagent is to visualize protein synthesis by confocal imaging whole-mount brains (as in Figures 2A, C and D). The data in previous Figures 4A and 4C were only intended to show that protein synthesis visualized in brains imaged by confocal microscopy was not merely derived from just a few labeled proteins, but from a range of proteins that span the molecular weight range of the gel.

In order to address the Reviewer’s concern, we have performed additional experiments to incorporate the requested control group for in-gel fluorescence assays and also to show total OPP-labeled protein from neuronal and glial proteomes by the biotin tagging and pulldown method, as described more below. Our new data clearly demonstrates strong signal-to-background for cell type-specific protein synthesis labeling by PhAcOPP, that matches the strong signal-to-background already seen in imaging data from fly brain and other tissues. This, coupled to data showing our ability to enrich for cell type-specific proteins following labeling in targeted cell populations provides rigorous quality control for our method and demonstrates its clear utility for achieving robust cell type-specific protein synthesis labeling.

Recommendations for the authors:

The negative control indicated by the Reviewer was included in the manuscript, not for the data in Figure 4, but for confocal imaging of protein synthesis in whole-mount brains. Specifically, we showed the absence of protein synthesis labeling when brains are incubated with PhAc-OPP but the PGA transgene is not expressed (see Figure 2—figure supplement 1b; data are for flies harboring UAS-PGA transgene but no GAL4 driver, therefore no PGA expression). Hence, we had previously addressed the possibility of PGA-independent PhAc-OPP uncaging and shown via the control group in Figure 2—figure supplement 1b that there is no substantial uncaging of PhAc-OPP without PGA expression.

However, to fully address any potential concerns of the Reviewer, we repeated the in-gel fluorescence assay incorporating the additional control group requested with brains incubated in PhAc-OPP but not expressing PGA (Figure 4A). For this control group, we chose flies that harbor the UAS-PGA transgene but no GAL4 driver, hence they are unable to express PGA. Exactly as seen with confocal brain imaging, this control group does not show any substantive protein synthesis labeling visualized by A488-azide signal (Figure 4A), again consistent with a lack of PhAc-OPP uncaging in the absence of PGA expression. We have added this new data as new Figure 4A and also added text to the Results (line 164) in order to describe this control group more clearly in the manuscript.

We performed the experiments requested in order to observe total biotin-tagged protein signal from neurons or glia following pulldown with neutravidin beads. The approach described by the reviewer (biotin-azide capture of OPP-labeled protein followed by pulldown with avidin beads) is the same approach we had used in blots to detect enrichment of individual neuron-specific or glial-specific proteins (now Figures 4C and F), hence we used these samples to blot for global biotin-tagged protein as requested by the Reviewer. We used anti-biotin to do this instead of streptavidinfluorophore suggested by the Reviewer, as anti-biotin is well validated for western blots on fly tissue (Reference (12)). Using this approach, we observe strong biotin-tagged protein signal in eluted fractions from PhAc-OPP-treated brains and very little background in the vehicle-treated control group likely corresponding to endogenously biotinylated proteins present in flies (new Figures 4B and E). Biotin-tagged protein can also be seen in inputs (whole lysates) for PhAc-OPP-treated brains and this is weaker than in eluted fractions, as would be expected. As the reviewer indicates, naturally biotinylated proteins are present in flies and can manifest as background on western blots. Consistent with this, we find one major non-specific band across all groups and present in both input and eluates. Hence, these new data demonstrate very high signalto-background for enriched biotin-tagged proteins. We believe these data address the concern about signal strength in in-gel fluorescence assays as pulldown of biotin tagged protein is a preferred method for assessing global labeling signal, as indicated by the Reviewer.

Considering our new data from analysis of total biotin-tagged neuronal/glial protein (new Figures 4B and 4E) alongside confocal imaging data from brains (Figure 2) and imaging data from other fly tissues such as muscle, trachea, salivary glands, fat body (Figure 3), we have now demonstrated that our method achieves robust signal over background for labeling newly-synthesized protein using two independent approaches. We have also shown that our method can be used to enrich cell typespecific labeled proteins from neurons and glia (now Figures 4C and 4F), thus verifying its use for assessing nascent proteomes of targeted cell populations. There are minor background bands for some (not all) enriched proteins, but these individual protein blots only detect near full-length labeled protein, whereas the total biotin blots should be able to detect all labeled protein or protein fragments and show a much greater signal-to-background strength (new Figures 4B and 4E). In future studies, we plan to use MS to query cell type-specific proteome changes under altered physiological or pathological conditions, yet it will require significant time, effort and funds to optimize and carry out MS studies. We believe that through the rigorous quality control experiments already performed, we have been able to effectively demonstrate high signal to background using two separate approaches, and therefore MS is not necessary for this purpose.

Reviewer #2 (Recommendations for the authors):

We are pleased that the changes made are satisfactory to the Reviewer. We have added PhAc-OPP to the Key Resources Table and cited the article in which its chemical synthesis is described in detail.